Form 8-K - Current report:
SEC Accession No. 0001193125-24-228399
Filing Date
2024-09-30
Accepted
2024-09-30 07:05:52
Documents
15
Period of Report
2024-09-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d829992d8k.htm   iXBRL 8-K 32568
2 EX-99.1 d829992dex991.htm EX-99.1 9777
6 GRAPHIC g829992g0926193456156.jpg GRAPHIC 2535
  Complete submission text file 0001193125-24-228399.txt   178744

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vor-20240930.xsd EX-101.SCH 2836
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vor-20240930_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vor-20240930_pre.xml EX-101.PRE 11699
17 EXTRACTED XBRL INSTANCE DOCUMENT d829992d8k_htm.xml XML 3767
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39979 | Film No.: 241336636
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)